Dopamine Antagonists (pharmacology) < Dopamine Antagonists (therapeutic use) < Dopamine Antagonists (toxicity)

Facettes :

List of bibliographic references indexed by Dopamine Antagonists (therapeutic use)

Number of relevant bibliographic references: 17.

Ident.	Authors (with country if any)	Title
000531 (2014)	Subhashie Wijemanne [États-Unis] ; Laura J C. Wu ; Joseph Jankovic [États-Unis]	Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
000C63 (2012)	Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl Kieburtz	Pharmacologic approaches to the treatment of Huntington's disease.
002231 (2009)	Han-Joon Kim [Corée du Sud] ; Joong-Yang Cho [Corée du Sud] ; Yong-Jin Cho [Corée du Sud] ; Keun-Sik Hong [Corée du Sud]	Levosulpiride‐induced resting orolingual tremor
002634 (2008)	Kersi J. Bharucha [États-Unis] ; Steve M. Blevins [États-Unis]	Sclerosing mesenteritis: An ergot‐related complication of pergolide therapy in Parkinson's disease?
002645 (2008)	Marcel J. H. Aries [Belgique] ; Hans Debruyne [Belgique] ; Sebastiaan Engelborghs [Belgique] ; Nathalie Le Bastard [Belgique] ; Nore Somers [Belgique] ; Dagmar Gorissen [Belgique] ; Barbara A. Pickut [Belgique] ; Peter Paul De Deyn [Belgique]	Reversal of head drop after discontinuation of olanzapine in a DLB patient
002D15 (2007)	Kerrie L. Schoffer [Australie] ; Robert D. Henderson [Australie] ; Karen O'Maley [Australie] ; John D. O'Sullivan [Australie]	Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease
003446 (2006)	Mazen Jabre [Liban] ; Boulos-Paul Bejjani [Liban]	Etiological and therapeutical observations in a case of belly dancer's dyskinesia
003589 (2006)	Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France]	Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors
003D98 (2004)	Aleksandar J. Risti [Yougoslavie] ; Marina Svetel [Yougoslavie] ; Nataša Dragaševi [Yougoslavie] ; Miloš Žarkovi [Yougoslavie] ; Katarina Koprivšek ; Vladimir S. Kosti [Yougoslavie]	Bilateral chorea–ballism associated with hyperthyroidism
004969 (2000)	Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]	Risperidone in the treatment of dopamine‐induced psychosis in Parkinson's disease: An open pilot trial
004C49 (1999)	Virgilio Gerald H. Evidente [États-Unis, Philippines] ; Katrina Gwinn-Hardy [États-Unis] ; John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis]	Risperidone is effective in severe hemichorea/hemiballismus
005359 (1997)	Irfan Soykan ; Irene Sarosiek [États-Unis] ; Jeannie Shifflett ; George F. Wooten [États-Unis] ; McCallum	Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with parkinson's disease
005660 (1996)	L. Verhagen Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; Chase [États-Unis]	Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
005708 (1996)	A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; F. García [Espagne] ; C. Cabezas [Espagne] ; F. Coria [Espagne] ; L. E. Clavería [Espagne]	An estimate of the risk of movement disorders associated with the chronic use of clebopride
005797 (1995)	M. Macucci ; M T Dotti ; A. Federico	Familial acute dystonic-dyskinetic syndrome with dominant inheritance after use of antidopaminergic antiemetic drugs.
005857 (1995)	Westermark [Suède] ; J. Tedroff [Suède] ; K. Thuomas [Suède] ; P. Hartvig [Suède] ; B. L Ngström [Suède] ; Y. Andersson [Suède] ; K. Hörnfeldt [Suède] ; S. Aquilonius [Suède]	Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers
005890 (1995)	Oertel [Allemagne] ; R. C. Dodel [Allemagne]	International guide to drugs for Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Antagonists (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Antagonists (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Antagonists (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024